In this respiratory disease roundup, researchers highlight the efficacy of clesrovimab in preventing respiratory syncytial virus infections in infants, the influenza vaccine's updated formulation this virus...
A recent study examined the relationship between influenza vaccination and the risk of hospitalization for community-acquired influenza-associated pneumonia.
A large, randomized trial in Denmark found no significant difference between high-dose and standard-dose influenza vaccines for preventing influenza- or pneumonia-related hospitalization in adults aged 65...
